SL Science Holding SLBT
NASDAQ SLBT
$0.90 -0.21 (-18.92%)
As of: Nov 5, 2026 · 2:02 PM EST

SL Science Holding (SLBT) Long-Term Investments (2025 - 2026)

Updated

SL Science Holding's Long-Term Investments came in at $39.39 million for Q1 2026, down 46.0% from the prior quarter.

Analysis

SL Science Holding (SLBT) Long-Term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, SL Science Holding's Long-Term Investments was $72.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,237.52 Bn 1,211.14 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 660.63 Bn 580.49 Bn 17.30 Bn -
3 AbbVie 516.15 Bn 484.16 Bn 13.12 Bn 387.00 Mn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 315.01 Bn 288.25 Bn - 63.00 Mn
6 Astrazeneca 291.28 Bn 265.17 Bn 13.26 Bn 268.00 Mn
7 Amgen 252.30 Bn 207.70 Bn 7.24 Bn -
8 Gilead Sciences 210.59 Bn 185.70 Bn 6.73 Bn -
9 Pfizer 172.71 Bn 120.07 Bn 12.56 Bn 1.45 Bn
10 SL Science Holding 1.96 Bn 1.95 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 39.39 Mn
Dec 31, 2025 72.92 Mn
API Access

SL Science Holding Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=SLBT&period=max&api_key=YOUR_API_KEY